Opportunity
Notice of Intent to Award a Sole Source Award For Cobalt-60 Reload of Foss Therapy Model 484F-C Cobalt-60 Irradiator
Response due
September 15, 2026
- Buyer
- Mrpbs Minneapolis Mn
- Agency
- Mrpbs Minneapolis Mn
- Estimated value
- Not stated
This Presolicitation Notice is issued pursuant to FAR 5.101(c) and serves as the Government’s Notice of Intent to award a sole source contract. The United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), Plant Protection and Quarantine (PPQ), Phoenix Rearing Facility (PRF), Phoenix, Arizona, intends to award a sole source purchase order to Foss Therapy Services, Inc. (UEI: TADAL13NTM57) under FAR Part 12 procedures. The requirement is for the Cobalt‑60 reload of the Foss Therapy Model 484F‑C irradiator, as detailed in the statement of work. Pricing shall include all costs necessary to perform the required services, including overhead, general and administrative expenses, profit, insurance, transportation, labor, equipment, and supplies. This notice does not constitute a competitive solicitation. Foss Therapy Services, Inc. retains proprietary rights to the designs, engineering tolerances, and mechanical specifications of the Model 484F‑C irradiator. Nevertheless, all responsible sources may submit a quotation or capability statement for consideration. Any entity that believes it can fulfill this requirement is encouraged to provide a capability statement for the Government’s review. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the Government’s discretion. Information received will be used exclusively to assess whether a competitive procurement should be conducted. The Government will not reimburse any costs incurred in responding to this notice. Parties wishing to express interest and submit a capability statement must do so no later than September 15, 2026. All responses and inquiries shall be submitted via email to Latisha Hollman at Latisha.A.Hollman@usda.gov.
Key dates
- Posted
- September 4, 2026
- Response due
- September 15, 2026
Who is this buyer
Organization
Buying history
- Records45 total
- Opportunities / awards3 / 8
- Value range$29,775 – $190,000
- ActiveJuly 16, 2026 – October 27, 2026
What they buy
- Clinical (26)
- Administrative (18)
- Insurance (1)
Set-asides used
- Small Business Set Aside - Total (26)
- No Set aside used (11)
Who holds their work today
- INGENESIS INC1 win · $190,000 · last December 4, 2025
- MARY GREELEY MEDICAL CENTER1 win · $93,469 · last April 1, 2026
- MCFARLAND CLINIC PC1 win · $36,366 · last October 16, 2020
Also open from this buyer
- Brand Name - Dectomax (Doramectin) 500mL Injectable SolutionDue October 30, 2026 · Clinical
- Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)Due November 10, 2026 · Clinical
- NAHLN Diagnostic Testing ServicesDue June 16, 2027 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Insurance
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 334517
- PSC
- 6525